scispace - formally typeset
H

Hongying Wu

Researcher at Peking Union Medical College

Publications -  13
Citations -  471

Hongying Wu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Lung cancer & Total body irradiation. The author has an hindex of 8, co-authored 13 publications receiving 424 citations.

Papers
More filters
Journal ArticleDOI

Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice.

TL;DR: Findings demonstrate that resveratrol can protect HSCs from radiation at least in part via activation of Sirt1 and has the potential to be used as an effective therapeutic agent to ameliorate TBI-induced long-term BM injury.
Journal ArticleDOI

Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer

TL;DR: 12 differently expressed miRNAs were found in the radiotherapy sensitive and resistant non-small cell lung cancer samples and results showed miRNA-126 promoted non- Small Cell lung cancer cells apoptosis induced by irradiation through the PI3K-Akt pathway.
Journal ArticleDOI

Expression of miRNA-130a in Nonsmall Cell Lung Cancer

TL;DR: It is shown, for the first time, that miRNA-130a expression is increased in nonsmall cell lung cancer (NSCLC) tissues, and data suggest that miRNAs may comprise a potential novel prognostic marker for this disease.
Journal ArticleDOI

Mitigating the Effects of Xuebijing Injection on Hematopoietic Cell Injury Induced by Total Body Irradiation with γ rays by Decreasing Reactive Oxygen Species Levels

TL;DR: XBJ enhances the survival rate of irradiated mice and attenuates the effects of radiation on hematopoietic injury by decreasing ROS production in BM cells, indicating that XBJ may be a promising therapeutic candidate for reducing hematopolietic radiation injury.
Journal ArticleDOI

Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation

TL;DR: It is demonstrated for the first time that decreased miRNA-22 expression correlates with increased radiotherapy resistance of ESCC, and that this effect is mediated, at least in part, by the Rad51 pathway.